NICHOLAS D'AMARIO: Open Payments
NPI 1952086969 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 26 payments from 13 companies in 2025. Trend: 2023 $343 · 2024 $751 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $171 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Astellas Pharma US Inc | 2 | $49 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
Products named: Ozempic, BREZTRI, JARDIANCE, Veozah, NURTEC ODT, The Cologuard Plus Collection Kit, Wegovy, GEMTESA.
Industry payments across MD — which companies pay providers there.
